在急性不补偿性心力衰竭中,营养和炎症生物标志物预测住院时间EF低于50
Mehmet Özyaşar1, Tolga Memioğlu2
1Cardiology Department, Konya City Hospital, Konya, Türkiye.
Frontiers in cardiovascular medicine
|March 5, 2026
概括
在急性不补偿性心力衰竭 (ADHF) 中,排泄率降低,营养状况不佳和高度炎症与更长的住院时间相关. 优化营养,特别是使用预后营养指数 (PNI),可能会改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 生物标志物研究 生物标志物研究
- 心脏衰竭管理的管理
背景情况:
- 营养和炎症标志物对急性不补偿性心力衰竭 (ADHF) 与左心室排气分数减少 (LVEF <50%) 的结局的综合影响尚不清楚.
- 现有证据强调了这些标记物在各种条件中的重要性,但它们在保存LVEF的ADHF中的特定作用需要进一步调查.
研究的目的:
- 研究营养和炎症生物标志物与ADHF和LVEF<50%的患者的临床结果之间的关联.
- 为了确定生物标志物,可以预测住院时间和在医院死亡率在这个患者群体.
主要方法:
- 一项对232名患有ADHF和LVEF<50%的患者的回顾性研究,这些患者在2024年1月至12月期间住院.
- 从入院血液样本中分析营养 (例如,白蛋白,血红蛋白,HALP,PNI) 和炎症 (例如,CRP,WBC,SII,SIRI) 生物标志物.
- 统计分析包括后勤回归和ROC分析,以确定与住院时间和死亡率的关联.
主要成果:
- 与住院时间较短的患者相比,长时间住院 (>5天) 的患者表现出较高的炎症标志物 (尿素,肌,CRP,WBC,SII,SIRI) 和较低的营养标志物 (白,,血红蛋白,HALP,PNI) 水平.
- 所有住院死亡 (n=15) 都发生在长期住院组中.
- 肝脏白蛋白与性酸酶比率 (HALP) 和预后营养指数 (PNI) 的较高水平独立地与更短的住院时间有关.
- 与HALP (AUC=0.679) 相比,PNI在较短的住院期间表现出更高的预测准确性 (AUC=0.85).
结论:
- 在LVEF<50%的ADHF患者中,营养状况不佳 (低HALP,PNI) 和高炎症负担 (高SII,SIRI) 与长时间住院有关.
- 较高的HALP和PNI水平预测了更短的住院时间,PNI是一个特别强大的预测因素.
- 以PNI等生物标志物为指导的营养优化可能是一个有价值的策略,以改善ADHF患者的临床结果.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
668
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
668
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.0K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Heart Failure II: Pathophysiology
1.2K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Heart Failure III: Clinical Manifestations
734
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
734
Heart Failure VII: Nursing Interventions
604
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
604
Heart Failure VI: Adjunct Therapies
486
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
486


